Thanks Mozz but you're fully invested here so potentially...

Thanks Mozz but you're fully invested here so potentially more suspectible to glossing over market realities.

PR has made himself a wealthy man by most metrics based on SHAREHOLDERs capital and NOT his own risked capital. He did take a $10m payday already from the sale of his board allocated shares. Admittedly he has purchased on market but only took up 20% of his allocation recently and not "50%" which he indicated in a webinar

All these consultants are great but will any drive outcomes we now need with the FDA? Based on IND and P3 staging I'm not convinced they can.

Having a founder be fully invested is a positive BUT you also need one that the market believes in.

Clock is ticking and the jury is certainly out on the direction PR has taking PAR in